ARTICLE
4 March 2015

Highlights From The FTC – DOJ Workshop Examining Health Care Competition

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Last week, the Federal Trade Commission and the Department of Justice co-hosted the second installment of their public workshop series, "Examining Health Care Competition."
United States Food, Drugs, Healthcare, Life Sciences

Last week, the Federal Trade Commission and the Department of Justice co-hosted the second installment of their public workshop series, "Examining Health Care Competition." The agencies' goal for the workshop was to identify and examine the potential competitive implications of strategies currently used by providers and payors seeking to reduce costs and improve quality.

In an Alert, Farrah Short of Mintz Levin's antitrust practice has summarized the workshop's discussions, which were informed by distinguished panelists from academia, government, and the private sector and focused on a broad range of policy positions.  Click here to read the full Alert.

The agencies are accepting public comments in response to the workshop until April 30, 2015.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More